These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3300302)

  • 1. New Medicare Conditions of Participation for Hospitals.
    Liang FZ; Greenberg RB; Hogan GF
    Am J Hosp Pharm; 1987 May; 44(5):1119-22. PubMed ID: 3300302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New JCAH standards affect medical staff, quality assurance.
    Kucera WR
    Health Prog; 1984 Nov; 65(10):38-43. PubMed ID: 10289591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASHP national survey of hospital-based pharmaceutical services--1992.
    Crawford SY; Myers CE
    Am J Hosp Pharm; 1993 Jul; 50(7):1371-404. PubMed ID: 8362870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASHP national survey of pharmaceutical services in federal hospitals--1993.
    Crawford SY; Santell JP
    Am J Hosp Pharm; 1994 Oct; 51(19):2377-93. PubMed ID: 7847403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of clinical pharmacy services through staff development.
    Greene SA; Powell CW
    Am J Hosp Pharm; 1991 Aug; 48(8):1704-8. PubMed ID: 1897549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous quality assurance monitoring by staff pharmacists.
    Spradling GF
    Hosp Pharm; 1990 Nov; 25(11):1021-4, 1027. PubMed ID: 10108872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and implementation of a quality-assurance program for pharmaceutical services.
    Horowitz KN; Lamnin M
    Am J Hosp Pharm; 1980 Jan; 37(1):82-4. PubMed ID: 7361777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conceptual framework for drug usage review, medical audit and other patient care review procedures.
    Stolar MH
    Am J Hosp Pharm; 1977 Feb; 34(2):139-45. PubMed ID: 842543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future pharmacy initiatives in institutional and corporate practice.
    Oddis JA
    Am J Hosp Pharm; 1984 Feb; 41(2):279-84. PubMed ID: 6702832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare and Medicaid programs; hospital conditions of participation; provider agreements and supplier approval--HCFA. Proposed rule.
    Fed Regist; 1997 Dec; 62(244):66726-63. PubMed ID: 10179304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program: changes to the hospital outpatient prospective payment system and CY 2008 payment rates, the ambulatory surgical center payment system and CY 2008 payment rates, the hospital inpatient prospective payment system and FY 2008 payment rates; and payments for graduate medical education for affiliated teaching hospitals in certain emergency situations Medicare and Medicaid programs: hospital conditions of participation; necessary provider designations of critical access hospitals. Interim and final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Nov; 72(227):66579-7226. PubMed ID: 18044033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical privileges program for pharmacists.
    Hutchison LC; Wolfe JJ; Padilla CB; Forrester CW
    Am J Hosp Pharm; 1992 Jun; 49(6):1422-4. PubMed ID: 1529982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare and Medicaid programs; conditions of participation for hospitals--HCFA. Final regulations.
    Fed Regist; 1986 Jun; 51(116):22010-52. PubMed ID: 10300760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic planning for clinical services: St. Joseph Hospital and Health Care Center.
    Linggi A; Pelham LD
    Am J Hosp Pharm; 1986 Sep; 43(9):2164-8. PubMed ID: 3532777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology.
    Bond CA; Raehl CL
    Pharmacotherapy; 2008 Jan; 28(1):1-13. PubMed ID: 18154468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare and Medicaid programs; hospital conditions of participation: requirements for history and physical examinations; authentication of verbal orders; securing medications; and postanesthesia evaluations. Final rule.
    Centers for Medicare & Medicaid Services (CMS), DHHS
    Fed Regist; 2006 Nov; 71(227):68671-95. PubMed ID: 17133696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care program improves reimbursement. The Federally Qualified Health Center program helps hospitals improve services to the medically indigent.
    Fahey TM; Gallitano DG
    Health Prog; 1993 Mar; 74(2):26-8, 30. PubMed ID: 10124301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare and Medicaid programs; rural hospitals: provision of long-term care services (swing-bed provision); flexibility in application of standards--Health Care Financing Administration. Interim final rule with comment period.
    Fed Regist; 1982 Jul; 47(139):31518-33. PubMed ID: 10298786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.